We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.09B
AUM Growth
+$1.38B
Cap. Flow
+$926M
Cap. Flow %
18.19%
Top 10 Hldgs %
35.13%
Holding
112
New
25
Increased
38
Reduced
18
Closed
24

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$137M
2
AGN.PRA
Allergan plc
AGN.PRA
+$89.2M
3
CNC icon
Centene
CNC
+$76.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$57.1M
5
JD icon
JD.com
JD
+$52M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$243M
2
UHS icon
Universal Health Services
UHS
+$91.1M
3
PCRX icon
Pacira BioSciences
PCRX
+$87.8M
4
MCK icon
McKesson
MCK
+$72.1M
5
BABA icon
Alibaba
BABA
+$54.9M

Sector Composition

Rank Sector Weight
1 Healthcare 33.12%
2 Technology 12.48%
3 Communication Services 5.27%
4 Consumer Discretionary 4.56%
5 Financials 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
101
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
– –
-1,647,600
Closed -$131M
CSOD
102
DELISTED
Cornerstone OnDemand, Inc.
CSOD
– –
-104,588
Closed -$3.74M
MDCO
103
CALL
DELISTED
Medicines Co
MDCO
– –
-1,107,200
Closed -$42.1M
ALDR
104
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-834,191
Closed -$9.55M
EVHC
105
DELISTED
Envision Healthcare Holdings Inc
EVHC
– –
-107,370
Closed -$6.73M
RXDX
106
DELISTED
Ignyta, Inc.
RXDX
– –
-1,820,496
Closed -$18.8M
SPNC
107
DELISTED
Spectranetics Corp
SPNC
– –
-675,383
Closed -$25.9M
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2017 Portfolio in Review

As of Q3 2017, PFM Health Sciences held 112 positions worth $5.09B, up 37% from $3.71B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences deployed $926M of net new capital in Q3 2017, opening 25 new positions and adding to 38 existing holdings. Its largest new stake was Allergan plc: 107,410 shares worth $79.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $243M trimmed.

  • PFM Health Sciences's largest Q3 2017 buy was Allergan plc: 107,410 shares worth $79.2M.
  • PFM Health Sciences added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $137M increase.
  • PFM Health Sciences's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $243M.
  • PFM Health Sciences fully exited Universal Health Services in Q3 2017, selling an estimated $91.1M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $5.09B portfolio in Q3 2017.
  • PFM Health Sciences opened 25 new positions and closed 24 in Q3 2017.
  • PFM Health Sciences's portfolio value rose 37% quarter-over-quarter to $5.09B.

Based on PFM Health Sciences's 13F filing for Q3 2017, filed 14 Nov 2017.